Analysis
Africa in 2025 is a high-potential, variable-stability proposition. UK investors will have to navigate political, legal, and fiscal risks skillfully—growth is there, but trust and state durability are imperative.
Investing in Africa in 2025: charting a course between ambition and changing realities Read More »
Acquisition of Innovative Monoclonal Antibody Scinai Immunotherapeutics (Nasdaq: SCNI) inked a binding option agreement to purchase Italian biotech company Pincell srl, taking an interest in PC111, a monoclonal antibody in development for severe dermatological conditions like Pemphigus, Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN). PC111 has received Orphan Drug Designation for Pemphigus from the
Scinai Immunotherapeutics into binding option agreement to acquire Pincell sr Read More »
23andMe seeks Chapter 11 bankruptcy, secures $35M DIP financing. CEO steps down, CFO appointed Interim CEO. Anticipates rejecting real property leases and resolving legal claims stemming from a 2023 cyber breach. 45-day bidding process for qualified buyers underway.
23andMe files for chapter 11 Bankruptcy to maximize business value Read More »
CGI has acquired Novatec, adding over 300 IT experts from Germany and Spain. This enhances CGI’s Stuttgart and Granada presence, increases its IP portfolio, and provides cultural fit. The acquisition positions CGI as a more competitive player in the European digital services market.
CGI completes purchase of Novatec: European digital services growth strategy Read More »
The UK economy faces recession risk with high interest rates and inflation expected to increase borrowing by £15 billion by 2030. Economic forecasts for 2025-2026 have been downgraded, and consumer sentiment has hit a 15-month low due to job insecurity and high taxes.
UK Economy on the brink of recession as spring statement awaits Read More »
PermRock Royalty Trust completes the sale of underlying oil and gas properties to T2S Permian Acquisition II, with Boaz Energy assisting in the transition. Boaz Energy also sold 4,884,861 Trust units to Ustx LLC, a subsidiary of T2S Permian. Argent Trust Company will continue normal administration.
PermRock Royalty trust closes significant transaction Read More »
R1 and Palantir Technologies launch R37, an AI lab transforming healthcare financial performance. Leveraging R1’s extensive data and Palantir’s AI, the lab aims to develop intelligent automation solutions for coding, billing, and denials management, with full deployment planned for H2 2025.
Sterling Bancorp (NASDAQ: SBT) completes the $261 million sale of Sterling Bank and Trust to EverBank Financial, effective April 1, 2025. All branches except Michigan will transition to EverBank, and Sterling will file for dissolution and delist from Nasdaq. Four directors have resigned.
Scinai Immunotherapeutics enters into a binding option agreement to acquire Pincell srl, focusing on PC111, a monoclonal antibody therapeutic for the treatment of severe skin diseases. An application for a €12 million grant is filed, with a decision expected in mid-July/early August 2025.
Scinai Immunotherapeutics into binding option agreement to acquire Pincell srl Read More »
The UK stock market in 2025 combines growth in technology, healthcare, and renewable energy sectors, with risks from high interest rates and geopolitical tensions. Caution is advised due to ongoing uncertainties.
UK stock market outlook for 2025: a mix of growth and caution Read More »
